9月2日，波士顿科学盘中上涨3.12%，报49.585美元/股，成交额5869.2万美元。
此前公司于8月25日发现网络安全事件，导致全球运营中断及部分客户订单处理与产品发运受阻；同期，FDA将其ENROUTE经皮导管召回划为最高严重等级，已报告一例严重伤害，双重利空叠加令股价一度下挫逾5%。随着公司确认中国区整体运营保持正常，并在第三方网络安全专家协助下推进系统恢复，市场恐慌情绪逐步消退，股价延续上周以来的反弹态势，目前已基本回升至事件发生前水平。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.